For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Telepsychiatry is a branch of telemedicine defined by the electronic delivery of psychiatric services to patients. This typically includes providing psychiatric assessments, therapeutic services, and medication management via telecommunication technology, most commonly videoconferencing.
LPI (LP Information)' newest research report, the "Telepsychiatry Industry Forecast" looks at past sales and reviews total world Telepsychiatry sales in 2022, providing a comprehensive analysis by region and market sector of projected Telepsychiatry sales for 2023 through 2029. With Telepsychiatry sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Telepsychiatry industry.
This Insight Report provides a comprehensive analysis of the global Telepsychiatry landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Telepsychiatry portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Telepsychiatry market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Telepsychiatry and breaks down the forecast by type, by end user, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Telepsychiatry.
The global Telepsychiatry market size is projected to grow from US$ 158.8 million in 2022 to US$ 710 million in 2029; it is expected to grow at a CAGR of 23.9% from 2023 to 2029.
Global Telepsychiatry key players include InSight Telepsychiatry, American Telepsychiatrists, Iris Telehealth, JSA Health, Advanced Telemed Services, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share over 80%, followed by Asia and Europe, both have a share over 10%.
In terms of application, the largest application is Adult, followed by Teenagers, Geriatric Populations, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Telepsychiatry market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Routine Telepsychiatry
- Forensic Telepsychiatry
- Crisis Telepsychiatry
- In-Home Telepsychiatry
Segmentation by end user
- Adults
- Teenagers
- Geriatric Populations
The below companies that are profiled
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- InSight Telepsychiatry
- American Telepsychiatrists
- Iris Telehealth
- JSA Health
- Advanced Telemed Services
- FasPsych
- Genoa
- Encounter Telehealth
- Arcadian Telepsychiatry
- InnovaTel